21.09
-0.05 (-0.24%)
| Penutupan Terdahulu | 21.14 |
| Jumlah Dagangan | 524,940 |
| Harga / Pendapatan (P/E Ke hadapan) | 18.34 |
| Harga / Jualan (P/S) | 1.39 |
| Harga / Buku (P/B) | 1.17 |
| Julat 52 Minggu |
| Margin Keuntungan | -7.50% |
| Margin Operasi (TTM) | -5.36% |
| EPS Cair (TTM) | -1.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 75.07% |
| Nisbah Semasa (MRQ) | 1.56 |
| Aliran Tunai Operasi (OCF TTM) | 166.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 69.00 M |
| Pulangan Atas Aset (ROA TTM) | 0.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.36% |
Sentimen Berita
-
Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
5 hari lalu, 10:27PM
-
Best Growth Stocks to Buy for November 13th
5 hari lalu, 1:25AM
-
Best Growth Stocks to Buy for November 11th
11 Nov, 1:44AM
AISkor Stockmoo
| Nilai 30% | 0.0 |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Hutang rendah. Keuntungan lemah. Aliran tunai positif. info | |
| Pulangan atas Modal info | NA |
| Masa 30% | 3.6 |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Tiada aliran jelas sepanjang tahun lalu. Didagangkan hampir paras tertinggi 52 minggu. info | |
| Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga telah naik jauh di atas purata itu. Dagangan lebih tinggi pada hari harga naik. info | |
| Corak Lilin info | NA |
| Di atas garis aliran jangka sederhana. info | |
| Sentimen 20% | 0.7 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Berita terkini kebanyakannya positif. info | |
| Wang Pintar 20% | -0.5 |
| Aktiviti Orang Dalam info | NA |
| Institusi bersih -0.28% daripada saham dalam pemfailan 13F terkini: 60 pemegang menambah, 35 mengurang (suku berakhir 30 Sep 2026). info | |
| Keadaan pasaran dan sektor neutral. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor mengatasi prestasi pasaran. | |
| Tonggak-tonggak sependapat, jadi skor diperkukuh. | |
| Tidak dikira dalam skor | |
| Harga tinggi berbanding purata 52 minggunya. info | |
| Aliran naik bagi ketiga-tiga tempoh. Momentum jangka pendek meningkat. info | |
| Harga hampir dengan paras rintangan. info | |
| Skor Akhir | 1.34 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Bausch + Lomb Corporation | Bercampur | Menaik |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| BLCO | - | - | - | 1.17 |
| RMD | - | 1.08% | - | 5.66 |
| BDX | - | 2.20% | - | 2.41 |
| WST | - | 0.37% | - | 9.67 |
| ALC | - | 0.49% | - | 1.64 |
| STVN | - | 0.30% | - | 2.39 |
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 88.13% |
| % Dimiliki oleh Institusi | 10.97% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Caspian Capital Lp | 30 Jun 2026 | 1,999,043 |
| Glenview Capital Management, Llc | 30 Jun 2026 | 1,918,148 |
| Clark Estates Inc/Ny | 30 Sep 2026 | 881,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Institusi
Pemilikan institusi: 10.66%
| Kedudukan | Pemegang | Saham |
|---|---|---|
| Bertambah | 60 | 5,333,667 |
| Berkurang | 35 | 5,694,076 |
| Baharu | 24 | 1,736,083 |
| Dijual habis | 9 | 2,368,991 |
Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 14 Nov 2026 | Yahoo Finance |
Bausch + Lomb (BLCO) Following Its Rally Is Fair Value Still In Sight
Bausch + Lomb (BLCO) has been drawing attention after recent trading, with the share price last closing at US$21.09. The move sits against a recent pattern of mixed short term and longer term returns. Over the past month, Bausch + Lomb has seen a sharp shift in momentum, with a 31.48% 30 day share… |
| 13 Nov 2026 | Yahoo Finance |
Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
Bausch + Lomb shares have moved higher in recent months, which puts a sharper spotlight on whether the current US$21.09 price lines up with the cash flows the business can realistically generate. After a solid stretch for the stock, the key issue for anyone looking at Bausch + Lomb today is how… |
| 13 Nov 2026 | Yahoo Finance |
Best Growth Stocks to Buy for November 13th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 13, 2026… |
| 11 Nov 2026 | Yahoo Finance |
Best Growth Stocks to Buy for November 11th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2026… |
| 06 Nov 2026 | Yahoo Finance |
Zacks.com featured highlights include Repsol, Bausch + Lomb, DMC Global, Universal Logistics and Methanex
Repsol, Bausch + Lomb and three other stocks show strong relative price strength, rising earnings estimates and potential for further gains. |
| 05 Nov 2026 | Yahoo Finance |
Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great Choice
Does Bausch + Lomb (BLCO) have what it takes to be a top stock pick for momentum investors? Let's find out. |
| 04 Nov 2026 | Yahoo Finance |
Bausch + Lomb: 3 Key Takeaways for Long-Term Investors
Premium product adoption is lifting margins faster than revenue growth, a sign of pricing power in a competitive market. |
| 04 Nov 2026 | Yahoo Finance |
Why Bausch + Lomb (BLCO) Might be Well Poised for a Surge
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. |
| 03 Nov 2026 | Yahoo Finance |
BLCO vs. HQY: Which Stock Is the Better Value Option?
BLCO vs. HQY: Which Stock Is the Better Value Option? |
Persediaan Teknikal Sederhana
AI Analisis Teknikal
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |